著書・論文Publications

著書

英文

  1. Risa Tamagawa-Mineoka, Mayumi Ueta, and Norihito Katoh: TLR3 and Inflammatory Skin Diseases: From Environmental Factors to Molecular Opportunities. pp 235-249, Springer; Skin Stress Response Pathways.2016.
  2. Mayumi Ueta: Stevens-Johnson syndrome with ocular complication. biopharmaceutics and drug hypersensitivity. Paul Mossillo & John Pinzini editors, p129-150. Nova Science Publishers, Inc, NY, 2010.
  3. Mayumi Ueta: Ethnic differences in the association of HLA and SJS. European Ophthalmic Review vol3 issue 1, p15-18. Touch Briefings, London, 2009.

和文

  1. 上田真由美, Stevens-Johnson症候群,眼科疾患最新の治療 (村上 昌、白石 敦、辻川明孝編) 2022.P105-106,南江堂
  2. 上田真由美,Stevens-Johnson症候群・中毒性表皮壊死症、9.皮膚疾患　4)粘膜・皮膚・眼症候群、眼疾患アトラスシリーズ、目と全身病アトラス、2020.P294-295 (ISBN978-4-88378-689-3) 、総合医学社
  3. 上田真由美,スティーブンス・ジョンソン症候群、 眼疾患アトラスシリーズ　‟眼病理アトラス“、p90-91, 2020、総合医学社
  4. 上田真由美,スティーブンス・ジョンソン症候群、眼疾患アトラスシリーズ　‟前眼部アトラス“、p48-49, 2020、総合医学社
  5. 上田真由美,アトピー性角結膜炎、眼疾患アトラスシリーズ　‟前眼部アトラス“、p46-47, 2020、総合医学社
  6. 上田真由美,II 部位別所見の見方　【角膜・結膜】アレルギー性疾患　春季カタル，アトピー性角結膜炎．細隙灯顕微鏡スキルアップ． 2019，18-19，メジカルビュー社．
  7. 上田真由美,II 部位別所見の見方【角膜・結膜】ステムセル疲弊症 Stevens-Johnson症候群，眼類天疱瘡．細隙灯顕微鏡スキルアップ．18-19，2019メジカルビュー社．
  8. 上田真由美,Stevens-Johnson症候群、眼科疾患、最新の治療2016-2018,p111, 2016、南江堂
  9. 上田真由美,眼表面の粘膜免疫機構. 角膜クリニック，2021 36-40医学書院.
  10. 上田真由美, Stevens-Johnson症候群、眼科診療マイスターII、診断と治療,p90-95, 2017, メジカルビュー社
  11. 上田真由美: Stevens-Johnson症候群. 眼科疾患　最新の治療2016-2018第１版、2016. P111. 南江堂
  12. 上田真由美: 上田真由美. Stevens-Johnson症候群.　一目でわかる眼疾患の見分け方. 角結膜疾患, 緑内障. 第１版、2016. P98-99. メジカルビュー社.
  13. 上田真由美, Stevens-Johnson症候群、今日の眼疾患治療指針第3版 2治療総論6角膜疾患, 2016. P365-368, 医学書院.
  14. 上田真由美, 眼類天疱瘡、今日の眼疾患治療指針　第3版 2治療総論5結膜疾患, 2016. P302-304, 医学書院.
  15. 上田真由美, 外園千恵: 全身疾患と関連する角膜異常，第10章前眼部疾患，小児眼科学，第１版，2015. 211-212. 三輪書店.
  16. 上田真由美,Stevens-Johnson症候群. 改訂2版　角膜疾患　外来でこう診てこう治せ.2015, 104-105， メジカルビュー社.
  17. 上田真由美,眼類天疱瘡と偽眼類天疱瘡. 改訂2版　角膜疾患　外来でこう診てこう治せ.2015, 106-107， メジカルビュー社.
  18. 上田真由美,移植片宿主病（GVHD）. 改訂2版　角膜疾患　外来でこう診てこう治せ. 2015,108-109， メジカルビュー社.
  19. 上田真由美, Wegener肉芽腫. 改訂2版　角膜疾患　外来でこう診てこう治せ. 2015,126-127， メジカルビュー社.
  20. 上田真由美, アレルギー性　(非感染性). 改訂2版　角膜疾患　外来でこう診てこう治せ. 2015,128-129， メジカルビュー社.
  21. 上田真由美: primaryなアレルギー結膜疾患の診断と治療、皮膚科・眼科連携マニュアル、目のまわりの病気とその治療、第１版、2015. P48-53. 秀潤社.
  22. 上田真由美, 外園千恵: Stevens-Johnson症候群の眼障害、、皮膚科・眼科連携マニュアル、目のまわりの病気とその治療、第１版、2015. P182-186. 秀潤社.
  23. 上田真由美, 外園千恵: Stevens-Johnson症候群.　全身疾患と関連する角膜異常. 第１０章前眼部疾患, 小児眼科学　第１版、2015. P211-213. 三輪書店
  24. 上田真由美, 外園千恵: Stevens-Johnson症候群の眼症状には点眼液？眼軟膏？、ヴィジュアルでみるステロイド外用薬の使い方ガイド、第１版、2015. P153-155. 学研メディカル秀潤社
  25. 上田真由美: 重篤な眼合併症を伴うStevens-Johnson症候群と関連のある遺伝子について教えてください. 専門医のための眼科診療クオリファイ. ２５角膜混濁のすべて.2014. p45-52.中山書店
  26. 上田真由美, 外園千恵: SJS/TENにおける眼症状の特徴. 皮膚科臨床アセット２“薬疹診療のフロントライン”. 2011, p71-73, 中山書店.
  27. 上田真由美, 外園千恵: SJS/TENの眼症状の治療と後遺症. 皮膚科臨床アセット２“薬疹診療のフロントライン”. 2011, p107-110, 中山書店.
  28. 上田真由美, 木下茂: 粘膜免疫と臨床 眼科との接点. 臨床粘膜免疫学（清野宏編）. 2010, p600-615, 株式会社シナジー.
  29. 上田真由美, 外園千恵: 重症薬疹では眼病変に注意. WHAT’S NEW IN 皮膚科学. 2010, p86-87, メディカルレビュー社.
  30. 上田真由美, 外園千恵: Stevens-Johnson症候群(SJS)の早期診断と早期治療のポイントは？. EBMアレルギー疾患の治療. 2008, p382-386, 中外医学社.
  31. 上田真由美, 外園千恵: Stevens-Johnson症候群. インストラクションコース. 2008, p98-110, メジカルビュー社 .
  32. 上田真由美: 緑膿菌感染、スリットで診る角膜疾患80 (木下茂編) . 2008, p52-53, メジカルビュー社.
  33. 上田真由美: CLによるぶどう球菌感染. スリットで診る角膜疾患80 (木下茂編) . 2008, p50-51, メジカルビュー社.
  34. 上田真由美: テリエン角膜変性. スリットで診る角膜疾患80 (木下茂編). 2008, p94-95, メジカルビュー社.
  35. 上田真由美: Stevens-Johnson症候群. スリットで診る角膜疾患80 (木下茂編). 2008, p86-87, メジカルビュー社.
  36. 上田真由美: 眼類天疱瘡と偽眼類天疱瘡. 角膜疾患外来でこう診てこう治せ (木下茂編). 2005, p100-101, メジカルビュー社.

原書

英文

  1. Ueta M.Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications.Front Med (Lausanne). 2021 Nov 17;8:651247.
  2. Ueta M.Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications.Front Med (Lausanne). 2021 Dec 1;8:649661.
  3. Kinoshita S, Ueta M. Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.Front Med (Lausanne). 2021 Dec 22;8:811570.
  4. Kinoshita F,Yokota I,Mieno H,Ueta M, Bush J,Kinoshita S,Sueki H,Asada H,Morita E,Fukushima M,Sotozono C,Teramukai S. Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis.; Japanese Research Committee on Severe Cutaneous Adverse Reaction. PLoS One. 2021 Dec 23;16(12):e0260730.
  5. Ueta M,Nishigaki H,Komai S,Sotozono C,Shigeru K. Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis.Immun Inflamm Dis. 2021 Dec;9(4):1815-1819.
  6. Sotozono C,Ueta M,Kinoshita S. Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications. Front. Med., 28 July 2021
  7. Ueta M,Nishigaki H,Mizushima K,Naito Y,Sotozono C,Kinoshita S. Regulation of innate immune response by miR-628-3p upregulated in the plasma of Stevens-Johnson syndrome patients. Ocul Surf. 2021 Jul;21:174-177.
  8. Ueta M,Hosomi K,Park J,Mizuguchi K,Sotozono C,Kinoshita S,Kunisawa J. Categorization of the Ocular Microbiome in Japanese Stevens-Johnson Syndrome Patients With Severe Ocular Complications. Front Cell Infect Microbiol. 2021 Nov 19;11:741654.
  9. Mieno H, Ueta M, Kinoshita F, Teramukai S, Kinoshita S, Sotozono C. Corticosteroid Pulse Therapy for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Patients with Acute Ocular Involvement. Am J Ophthalmol. 2021 Jun 29:S0002-9394(21)00340-8.
  10. Ueta M, Nishigaki H, Mizushima K, Naito Y, Sotozono C, Kinoshita S. Regulation of innate immune response by miR-628-3p upregulated in the plasma of Stevens-Johnson syndrome patients. Ocul Surf. 2021 Jul;21:174-177.
  11. Komai S, Inatomi T, Nakamura T, Ueta M, Horiguchi G, Teramukai S, Kimura Y, Kagimura T, Fukushima M, Kinoshita S, Sotozono C. Long-term outcome of cultivated oral mucosal epithelial transplantation for fornix reconstruction in chronic cicatrising diseases. Br J Ophthalmol. 2021 May 18:bjophthalmol-2020-318547.
  12. Gervais O, Ueno K, Kawai Y, Hitomi Y, Aiba Y, Ueta M, Nakamura M, Tokunaga K, Nagasaki M. Regional heritability mapping identifies several novel loci (STAT4, ULK4, and KCNH5) for primary biliary cholangitis in the Japanese population. Eur J Hum Genet. 2021 Aug;29(8):1282-1291.
  13. Wakamatsu TH, Ueta M, Inoue C, Costa KA, Sakano LY, Sallum JM, Gomes JÁ, Kinoshita S. Human Leukocyte Antigen Class I and II Genes Associated with Dipyrone-Related Stevens-Johnson Syndrome and Severe Ocular Complications in a Brazilian Population. Ocul Surf. 2021 Feb 19;20:173-175.
  14. Kawai Y, Hitomi Y, Ueta M, Khor SS, Nakatani K, Sotozono C, Kinoshita S, Nagasaki M, Tokunaga K. Mapping of susceptible variants for cold medicine-related Stevens-Johnson syndrome by whole-genome resequencing. NPJ Genom Med. 2021 Feb 11;6(1):9.
  15. Butt GF, Hassan A, Wallace GR, Kinoshita S, Ahmad S, Ueta M, Rauz S. Human leukocyte antigen B*0702 is protective against ocular Stevens-Johnson syndrome/toxic epidermal necrolysis in the UK population. Sci Rep. 2021 Feb 3;11(1):2928.
  16. Ma KS, Chung WH, Hsueh YJ, Chen SY, Tokunaga K, Kinoshita S, Ma DHK, Ueta M. Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese. Br J Ophthalmol. 2021 Jan 13:bjophthalmol-2020-317105.
  17. Tamagawa-Mineoka R, Ueta M, Arakawa Y, Yasuike R, Nishigaki H, Okuno Y, Hijikuro I, Kinoshita S, Katoh N. Topical application of toll-like receptor 3 inhibitors ameliorates chronic allergic skin inflammation in mice. J Dermatol Sci. 2020 Nov 24:S0923-1811(20)30375-3.
  18. Jongkhajornpong P, Ueta M, Lekhanont K, Puangsricharern V, Prabhasawat P, Chantaren P, Pisuchpen P, Kinoshita S. Association of HLA polymorphisms and acetaminophen-related Steven-Johnson syndrome with severe ocular complications in Thai population. Br J Ophthalmol. 2020 Nov 23:bjophthalmol-2020-317315.
  19. Yoshikawa Y, Ueta M, Nishigaki H, Kinoshita S, Ikeda T, Sotozono C. Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis. Sci Rep. 2020 Nov 3;10(1):18922.
  20. Sotozono C, Inatomi T, Nakamura T, Ueta M, Imai K, Fukuoka H, Komai S, Ishida G, Kitazawa K, Yokoi N, Koizumi N, Kimura Y, Go M, Fukushima M, Kinoshita S. Oral Mucosal Epithelial Transplantation and Limbal-Rigid Contact Lens: A Therapeutic Modality for the Treatment of Severe Ocular Surface Disorders. Cornea. 2020 Nov;39 Suppl 1:S19-S27.
  21. Ueta M, Nishigaki H, Sotozono C, Yokoi N, Mizushima K, Naito Y, Kinoshita S. Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. Sci Rep. 2020 Oct 14;10(1):17239.
  22. Sunaga Y, Kurosawa M, Ochiai H, Watanabe H, Sueki H, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hama N, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Kokaze A. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018. J Dermatol Sci. 2020 Dec;100(3):175-182.
  23. Tangamornsuksan W, Chanprasert S, Nadee P, Rungruang S, Meesilsat N, Ueta M, Lohitnavy M. HLA genotypes and cold medicine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis. Sci Rep. 2020 Jun 29;10(1):10589.
  24. Itoi M, Ueta M, Ogino K, Sumi E, Imai K, Teramukai S, Kinoshita S, Sotozono C. Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome/toxic epidermal necrolysis. Cont Lens Anterior Eye. 2020 Dec;43(6):535-542.
  25. Chang WC, Abe R, Anderson P, Anderson W, Ardern-Jones MR, Beachkofsky TM, Bellón T, Biala AK, Bouchard C, Cavalleri GL, Chapman N, Chodosh J, Choi HK, Cibotti RR, Divito SJ, Dewar K, Dehaeck U, Etminan M, Forbes D, Fuchs E, Goldman JL, Holmes JH 4th, Hope EA, Hung SI, Hsieh CL, Iovieno A, Jagdeo J, Kim MK, Koelle DM, Lacouture ME, Le Pallec S, Lehloenya RJ, Lim R, Lowe A, McCawley J, McCawley J, Micheletti RG, Mockenhaupt M, Niemeyer K, Norcross MA, Oboh D, Olteanu C, Pasieka HB, Peter J, Pirmohamed M, Rieder M, Saeed HN, Shear NH, Shieh C, Straus S, Sukasem C, Sung C, Trubiano JA, Tsou SY, Ueta M, Volpi S, Wan C, Wang H, Wang ZQ, Weintraub J, Whale C, Wheatley LM, Whyte-Croasdaile S, Williams KB, Wright G, Yeung SN, Zhou L, Chung WH, Phillips EJ, Carleton BC. SJS/TEN 2019: From science to translation. J Dermatol Sci. 2020 Apr;98(1):2-12.
  26. Ueta M. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications. Expert Rev Clin Immunol. 2020 Mar;16(3):285-291.
  27. Kaneko Y, Seko Y, Sotozono C, Ueta M, Sato S, Shimamoto T, Iwasaku M, Yamada T, Uchino J, Hizawa N, Takayama K. Respiratory complications of Stevens-Johnson syndrome (SJS): 3 cases of SJS-induced obstructive bronchiolitis. Allergol Int. 2020 Feb 14:S1323-8930(20)30009-5.
  28. Yoshikawa Y, Ueta M, Fukuoka H, Inatomi T, Yokota I, Teramukai S, Yokoi N, Kinoshita S, Tajiri K, Ikeda T, Sotozono C. Long-term Progression of Ocular Surface Disease in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Cornea. 2020 Jun;39(6):745-753.
  29. Chantaren P, Jongkhajornpong P, Ueta M, Puangsricharern V, Lekhanont K, Pisuchpen P, Prabhasawat P, Suphapeetiporn K, Kinoshita S. Association of IKZF1 SNPs in cold medicine-related Stevens-Johnson syndrome in Thailand. Clin Transl Allergy. 2019 Nov 22;9:61.
  30. Nakatani K, Ueta M, Khor SS, Hitomi Y, Okudaira Y, Masuya A, Wada Y, Sotozono C, Kinoshita S, Inoko H, Tokunaga K. Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing. Sci Rep. 2019 Nov 7;9(1):16240.
  31. Ueta M, Nakamura R, Saito Y, Tokunaga K, Sotozono C, Yabe T, Aihara M, Matsunaga K, Kinoshita S. Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens-Johnson syndrome with severe ocular complications in Japanese individuals. Hum Genome Var. 2019 Oct 28;6:50.
  32. Ueta M, Sotozono C, Nishigaki H, Ohsako S, Yokoi N, Mizushima K, Naito Y, Kinoshita S. Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage. BMJ Open Ophthalmol. 2019 Jun 16;4(1):e000254.
  33. Shrestha T, Moon HS, Choi W, Yoon HJ, Ji YS, Ueta M, Yoon KC. Characteristics of meibomian gland dysfunction in patients with Stevens-Johnson syndrome. Medicine (Baltimore). 2019 Jun;98(26):e16155.
  34. Nakamura N, Tamagawa-Mineoka R, Ueta M, Konishi E, Yasuike R, Masuda K, Matsunaka H, Murakami Y, Yokosawa E, Katoh N.　Stratum corneum Toll-like receptor 3 expressions correlate with the severity of atopic dermatitis lesions.　J Dermatol Sci. 2019 J Dermatol Sci. 2019 Jun;94(3):354-357.
  35. Mieno H, Ueta M, Yamada K, Yamanaka Y, Nakayama T, Watanabe A, Kinoshita S, Sotozono C. Expression of prostaglandin E2 receptor 3 in the eyelid epidermis of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.　 Br J Ophthalmol. 2020 Jul;104(7):1022-1027.
  36. Jun I, Rim JH, Kim MK, Yoon KC, Joo CK, Kinoshita S, Seo KY, Ueta M. Association of human antigen class I genes with cold medicine-related Stevens-Johnson syndrome with severe ocular complications in a Korean population. Br J Ophthalmol. Br J Ophthalmol. 2019 Apr;103(4):573-576.
  37. Ueta M, Hamuro J, Ohsako S, Kinoshita S.Distinctly regulated functions and mobilization of CD11c-positive cells elicited by TLR3- and IPS-1 signaling in the cornea.　 immunol Lett. Immunol Lett. 2019 ;206:49-53.
  38. Ueta M.　Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.　Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES183-DES191.
  39. Sotozono C, Ueta M, Yokoi N.　Severe Dry Eye With Combined Mechanisms is Involved in the Ocular Sequelae of SJS/TEN at the Chronic Stage.　Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES80-DES86.
  40. Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH. HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. Clin Pharmacol Ther. 2019 Feb;105(2):476-485.
  41. Miyazaki D, Shimizu D, Shimizu Y, Inoue Y, Inoue T, Higaki S, Ueta M, Sugita S; Real-time PCR for ocular cytomegalovirus infection study group. Diagnostic efficacy of real-time PCR for ocular cytomegalovirus infections. Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2413-2420.
  42. Jongkhajornpong P, Lekhanont K, Pisuchpen P, Chantaren P, Puangsricharern V, Prabhasawat P, Suphapeetiporn K, Kinoshita S, Ueta M. Association between HLA-B*44:03-HLA-C*07:01 haplotype and cold medicine-related Stevens-Johnson syndrome with severe ocular complications in Thailand. Br J Ophthalmol. 2018 Sep;102(9):1303-1307.
  43. Tamagawa-Mineoka R, Yasuoka N, Ueta M, Katoh N. Influence of topical steroids on intraocular pressure in patients with atopic dermatitis.　Allergol Int. 2018 Jul;67(3):388-391．
  44. Shinomiya K, Ueta M, Kinoshita S. A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision. Sci Rep. 2018 Jan 24;8(1):1483.
  45. Ueta M, Nishigaki H, Sotozono C, Kinoshita S. Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage. BMJ Open Ophthalmol. 2017 Aug 7;1(1):e000073.
  46. Yoon HJ, Kim MK, Seo KY, Ueta M, Yoon KC.　Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bev cizumab for corneal neovascularization in Stevens-Johnson syndrome. Int Ophthalmol. 2019 Jan;39(1):55-62.
  47. Kannabiran C, Ueta M, Sangwan V, Rathi V, Basu S, Tokunaga K, Kinoshita S. Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population. Sci Rep. 2017 Nov 21;7(1):15960.
  48. Lee HK, Yoon KC, Seo KY, Ueta M, Kim MK. Chronic ocular complications of Stevens-Johnson syndrome associated with causative medications in Korea. J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):700-702.e2.　(2016 IF=5.317)
  49. Ueta M, Hamuro J, Nishigaki H, Nakamura N, Shinomiya K, Mizushima K, Hitomi Y, Tamagawa-Mineoka R, Yokoi N, Naito Y, Tokunaga K, Katoh N, Sotozono C, Kinoshita S. Mucocutaneous Inflammation in the Ikaros Family Zinc Finger 1 (IKZF1) - keratin 5 specifc transgenic mice. Allergy. 2017 Sep 15. [Epub ahead of print]
  50. Yasuike R, Tamagawa-Mineoka R, Ueta M, Nakamura N, Kinoshita S, Katoh N. The role of toll-like receptor 3 in chronic contact hypersensitivity induced by repeated elicitation. J Dermatol Sci. 2017 Aug 4. 2017.07.017. [Epub ahead of print]
  51. Okada Y, Ueta M. Data Sparsity in Study on Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications-Reply. JAMA Ophthalmol. 2017 Jul 13.
  52. Wakamatsu TH, Ueta M, Tokunaga K, Okada Y, Loureiro RR, Costa KA, Sallum JM, Milhomens JA, Inoue C, Sotozono C, Gomes JÁ, Kinoshita S. Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population. JAMA Ophthalmol. 2017 Apr 1;135(4):355-360.
  53. Ueta M， Sawai H， Shingaki R, Kawai Y, Sotozono C， Kojima K, Yoon KC， Kim MK， Seo KY， Joo CK， Nagasaki M, Kinoshita S， Tokunaga K. Genome-wide association study using the ethnicity-specific Japonica array: Identification of new susceptibility loci for cold medicine-related Stevens-Johnson syndrome with severe ocular complications. J Human Genetics. 2017 Apr;62(4):485-489.
  54. Saito K, Ueta M, Maekawa K, Sotozono C, Kinoshita S, Saito Y.　Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.　 PLoS One. 2016 Nov 29;11(11):e0167402.
  55. Jain R, Sharma N, Basu S, Iyer G, Ueta M, Sotozono C, Kannibiran C, Rathi VM, Gupta N, Kinoshita S, Gomes JA, Chodosh J, Sangwan VS. Reply: Amniotic membrane transplantation in Stevens-Johnson Syndrome. Surv Ophthalmol. Surv Ophthalmol. 2017 Mar - Apr;62(2):249-250.
  56. Koizumi N, Miyazaki D, Inoue T, Ohtani F, Kandori-Inoue M, Inatomi T, Sotozono C, Nakagawa H, Horikiri T, Ueta M, Nakamura T, Inoue Y, Ohashi Y, Kinoshita S. The effect of topical application of 0.15% ganciclovir gel on cytomegalovirus corneal endotheliitis. Br J Ophthalmol. 2017 Feb;101(2):114-119.
  57. Kojima S, Inoue T, Kikuta J, Furuya M, Koga A, Fujimoto T, Ueta M, Kinoshita S, Ishii M, Tanihara H.　Visualization of Intravital Immune Cell Dynamics After Conjunctival Surgery Using Multiphoton Microscopy. Invest Ophthalmol Vis Sci. 2016 Mar 1;57(3):1207-12.
  58. Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai X, Gomes JA, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DT, Tandon R, Tseng SC, Ueta M, Chodosh J. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. Ocul Surf. 2016 Feb 12. pii: S1542-0124(16)00011-2.
  59. Jain R, Sharma N, Basu S, Iyer G, Ueta M, Sotozono C, Kannibiran C, Rathi VM, Gupta N, Kinoshita S, Gomes JA, Chodosh J, Sangwan VS. Stevens Johnsons Syndrome: The Role of an Ophthalmologist. Surv Ophthalmol. 2016 Jan 29. pii: S0039-6257(16)00003-5.
  60. Lee HS, Ueta M, Kim MK, Seo KY, Sotozono C, Kinoshita S, Yoon KC. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea. Cornea. 2016 Feb;35(2):199-204.
  61. Ueta M, Koga A, Kikuta J, Yamada K, Kojima S, Shinomiya K, Ishii M, Kinoshita S. Intravital imaging of the cellular dynamics of LysM-positive cells in a murine corneal suture model. Br J Ophthalmol. 2016 Mar;100(3):432-5.
  62. Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, Blomquist PH, Bouchard CS, Dart JK, Gai X, Gomes JA, Gregory DG, Iyer G, Jacobs DS, Johnson AJ, Kinoshita S, Mantagos IS, Mehta JS, Perez VL, Pflugfelder SC, Sangwan VS, Sippel KC, Sotozono C, Srinivasan B, Tan DT, Tandon R, Tseng SC, Ueta M, Chodosh J. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. I. Systemic Disease.Ocul Surf. 2016 Jan;14(1):2-19.
  63. Passara Jongkhajornpong, Kaevalin Lekhanont, Mayumi Ueta, Koji Kitazawa, Satoshi Kawasaki& Shigeru Kinoshita. Novel TACSTD2 mutation in gelatinous drop-like corneal dystrophy. Human Genome Variation 2, 15047
  64. Mayumi Ueta, Katsushi Tokunaga, Chie Sotozono, Hiromi Sawai, Kyung-Chul Yoon, Mee Kum Kim, Kyoung Yul Seo, Choun-Ki Joo, Kei Tashiro & Shigeru Kinoshita. HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens?Johnson syndrome with severe ocular complications. Human Genome Variation 2, 15023.
  65. Maekawa K, Nakamura R, Kaniwa N, Mizusawa S, Kitamoto A, Kitamoto T, Ukaji M, Matsuzawa Y, Sugiyama E, Uchida Y, Kurose K, Ueta M, Sotozono C, Ikeda H, Yagami A, Matsukura S, Kinoshita S, Muramatsu M, Ikezawa Z, Sekine A, Furuya H, Takahashi Y, Matsunaga K, Aihara M, Saito Y; Japan Pharmacogenomics Data Science Consortium. Development of a simple genotyping method for the HLA-A*31:01-tagging SNP in Japanese. Pharmacogenomics. 2015 Oct;16(15):1689-99.
  66. Ueta M. Genetic Predisposition to Stevens-Johnson Syndrome With Severe Ocular Surface Complications. Cornea. 2015 Nov;34 Suppl 11:S158-65.
  67. Kaniwa N, Ueta M, Nakamura R, Okamoto-Uchida Y, Sugiyama E, Maekawa K, Takahashi Y, Furuya H, Yagami A, Matsukura S, Ikezawa Z, Matsunaga K, Sotozono C, Aihara M, Kinoshita S, Saito Y. Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome/toxic epidermal necrolysis. Allergol Int. 2015 Oct;64(4):379-81.
  68. Sotozono C, Ueta M, Nakatani E, Kitami A, Watanabe H, Sueki H, Iijima M, Aihara M, Ikezawa Z, Aihara Y, Kano Y, Shiohara T, Tohyama M, Shirakata Y, Kaneda H, Fukushima M, Kinoshita S, Hashimoto K. Predictive Factors associated with Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Am J Ophthalmol2015 Aug;160(2):228-237.e2.
  69. Ueta M, Sawai H, Sotozono C, Hitomi Y, Kaniwa N, Kim MK, Seo KY, Yoon KC, Joo CK, Kannabiran C, Wakamatsu TH, Sangwan V, Rathi V, Basu S, Ozeki T, Mushiroda T, Sugiyama E, Maekawa K, Nakamura R, Aihara M, Matsunaga K, Sekine A, Gomes JAP, Hamuro J, Saito Y, Kubo M, Kinoshita S, Tokunaga K. New Susceptibility Gene, IKZF1, for Cold Medicine?Related Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis with Severe Mucosal Involvements. J Allergy Clin Immunol. 2015 Jun;135(6):1538-1545.e17.
  70. Ueta M, Shoji J, Sotozono C, Kinoshita K. Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops. Clinical and Translational Allergy, 2014 Oct 30;4:40.
  71. Nakamura N, Tamagawa-Mineoka R, Ueta M, Kinoshita S, Katoh N. Toll-Like Receptor 3 Increases Allergic and Irritant Contact Dermatitis. J Invest Dermatol. 2015 Feb;135(2):411-7.
  72. Kim DH, Yoon KC, Seo KY, Lee HS, Yoon SC, Sotozono C, Ueta M, Kim MK. The Role of Systemic Immunomodulatory Treatment and Prognostic Factors on Chronic Ocular Complications in Stevens-Johnson Syndrome. Ophthalmology. 2015 Feb;122(2):254-64..
  73. Ueta M, Kannabiran C, Wakamatsu TH, Kim MK, Yoon KC, Seo KY, Joo CK, Sangwan V, Rathi V, Basu S, Shamaila A, Lee HS, Yoon S, Sotozono C, Gomes JAP, Tokunaga K, Kinoshita S. Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications. Sci Rep. 2014 ;4:5981.
  74. Sotozono C, Inatomi T, Nakamura T, Koizumi N, Yokoi N, Ueta M, Matsuyama K, Kaneda H, Fukushima M, Kinoshita S. Cultivated oral mucosal epithelial transplantation for persistent epithelial defect in severe ocular surface diseases with acute inflammatory activity. Acta Ophthalmol. 2014 ; 92(6):e447-53.
  75. Yamada K, Ueta M, Sotozono C, Yokoi N, Inatomi T, Kinoshita S. Upregulation of Toll-like receptor 5 expression in the conjunctival epithelium of various human ocular surface diseases. Br J Ophthalmol. 2014 ;. 98(8):1116-9.
  76. Ueta M, Kaniwa N, Sotozono C, Tokunaga K, Saito Y, Sawai H, Miyadera H, Sugiyama E, Maekawa K, Nakamura R, Nagato M, Aihara M, Matsunaga K, Takahashi Y, Furuya H, Muramatsu M, Ikezawa Z, Kinoshita S.Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement. Sci Rep. 2014;4:4862.
  77. Ueta M, Sotozono C, Koga A, Yokoi N, Kinoshita S. Usefulness of a New Therapy Using Rebamipide Eyedrops in Patients with VKC/AKC Refractory to Conventional Anti-Allergic Treatments. Allergol Int. 2014 63:75-81
  78. Isogai H, Miyadera H, Ueta M, Sotozono C, Kinoshita S, Tokunaga K, Hirayama N. In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients. J Toxicol. 2013;2013:514068.
  79. Kaniwa N, Sugiyama E, Saito Y, Kurose K, Maekawa K, Hasegawa R, Furuya H, Ikeda H, Takahashi Y, Muramatsu M, Tohkin M, Ozeki T, Mushiroda T, Kubo M, Kamatani N, Abe M, Yagami A, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z, Matsunaga K, Aihara M. Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects. Pharmacogenomics. 2013. 14:1821-31
  80. Ueta M, Mizushima K, Naito Y, Narumiya S, Shinomiya K,1 Kinoshita S. Suppression of polyI:C-inducible gene expression by EP3 in murine conjunctival epithelium. Immunol Lett. 2013 Sep 12. pii: S0165-2478(13)00121-1.
  81. Watanabe A, Sotozono C, Ueta M, Katsuhiko Shinomiya, Kinoshita S, Kakizaki H, Selva D, FRANZCO F. Folliculitis in Clinically “Quiet” Chronic Stevens-Johnson syndrome. Ophthal Plast Reconstr Surg. 2014, 30:80-2.
  82. Ueta M, Sotozono C, Yokoi N, Kinoshita S:　Rebamipide Suppresses PolyI:C-Stimulated Cytokine Production in Human Conjunctival Epithelial Cells. J Ocul Pharmacol Ther. 2013 Sep;29(7):688-93.
  83. Shinomiya K, Ueta M, Sotozono C,Inatomi T, Yokoi N, Koizumi N, Kinoshita S: Immunohistochemical analysis of inflammatory limbal conjunctiva adjacent to Mooren's ulcer. Br J Ophthalmol. 2013;　97(3):362-6
  84. Sotozono C, Inatomi T, Nakamura T, Koizumi N, Yokoi N, Ueta M, Matsuyama K, Miyakoda K, Kaneda H, Fukushima M, Kinoshita S: Visual Improvement after Cultivated Oral Mucosal Epithelial Transplantation. Ophthalmology. 2013; 120(1): 193-200.
  85. Ueta M: Epistatic interactions associated with stevens-johnson syndrome. Cornea. 2012; Suppl 1:S57-62
  86. Ueta M, Sotozono C, Yamada K, Yokoi N, Inatomi T, Kinoshita S: Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study. BMJ Open. 2012; 2(5): pii: e001330.
  87. Ueta M, Tokunaga K, Sotozono C, Sawai H, Tamiya G, Inatomi T, Kinoshita S: HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications. PLoS One. 2012; 7(8):e43650.
  88. Ueta M, Kinoshita S: Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res. 2012; 31(6): 551-575.
  89. Imai K, Ueta M, Mori K, Ueno M, Ikeda Y, Oga T, Yokoi N, Shinomiya K, Narumiya S, Kinoshita S: Expression of prostaglandin F receptor in scleral and subconjunctival tissue. Br J Ophthalmol. 2012; 96(8): 1148-1149.
  90. Ueta M, Matsuoka T, Sotozono C, Kinoshita S: Prostaglandin E2 Suppresses Poly I: C-Stimulated Cytokine Production Via EP2 and EP3 in Immortalized Human Corneal Epithelial Cells. Cornea. 2012; 31(11): 1294-1298.
  91. Ueta M, Tamiya G, Tokunaga K, Sotozono C, Ueki M, Sawai H, Inatomi T, Matsuoka T, Akira S, Narumiya S, Tashiro K, Kinoshita S: Epistatic interaction between Toll-like receptor 3 (TLR3) and prostaglandin E receptor 3 (PTGER3) genes.　J Allergy Clin Immunol. 2012; 129(5): 1413-1416.e11.
  92. Ueta M, Sotozono C, Yokoi N, Kinoshita S: Downregulation of monocyte chemoattractant protein 1 expression by prostaglandin e2 in human ocular surface epithelium. Arch Ophthalmol. 2012; 130(2): 249-251.
  93. Ueta M, Yokoi N, Kinoshita S: Endothelin-1 production upon polyI:C stimulation of human conjunctival epithelium. Br J Ophthalmol. 2011; 95(12):1760-1761.
  94. Ueta M, Sotozono C, Yokoi N, Inatomi T, Kinoshita S: Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders. PLoS One. 2011; 6(9): e25209.
  95. Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z: A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Pharmacogenomics J. 2013 ;13(1):60-9.
  96. Ueta M, Sotozono C, Kinoshita S: Expression of interleukin-4 receptor α in human corneal epithelial cells. Jpn J Ophthalmol. 2011; 55(4): 405-410.
  97. Yagi T, Sotozono C, Tanaka M, Fuwa M, Sekiyama E, Ueta M, Tashiro K, Kinoshita S: Cytokine storm arising on the ocular surface in a patient with Stevens-Johnson syndrome. Br J Ophthalmol. 2011; 95(7): 1030-1031.
  98. Ueta M, Matsuoka T, Yokoi N, Kinoshita S: Prostaglandin E2 suppresses polyinosine-polycytidylic acid (polyI:C)-stimulated cytokine production via prostaglandin (EP) 2 and 3 in human conjunctival epithelial cells. Br J Ophthalmol. 2011; 95(6): 859-863.
  99. Ueta M, Matsuoka T, Yokoi N, Kinoshita S: Prostaglandin E receptor subtype EP3 downregulates TSLP expression in human conjunctival epithelium. Br J Ophthalmol. 2011; 95(5): 742-743.
  100. Ueta M, Kawai T, Yokoi N, Akira S, Kinoshita S: Contribution of IPS-1 to polyI:C-induced cytokine production in conjunctival epithelial cells. Biochem Biophys Res Commun. 2011; 404(1): 419-423.
  101. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R: JSAR research group. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia. 2010; 51(12): 2461-2465.
  102. Ueta M: Regulation of ocular surface inflammation by prostaglandin E receptor subtype EP3. Cornea. 2010; 29(11): S57-61.
  103. Ueta M, Sotozono C, Nakano M, Taniguchi T, Yagi T, Tokuda Y, Fuwa M, Inatomi T, Yokoi N, Tashiro K, Kinoshita S: Association between prostaglandin E receptor 3 polymorphisms and Stevens-Johnson syndrome identified by means of a genome-wide association study. J Allergy Clin Immunol. 2010; 126(6): 1218-1225.
  104. Ueta M, Sotozono C, Yokoi N, Inatomi T, Kinoshita S: Prostaglandin E receptor 4 expression in human conjunctival epithelium and its downregulation in devastating ocular surface inflammatory disorders. Arch Ophthalmol. 2010; 128(10): 1369-1371.
  105. Ueta M, Hamuro J, Kinoshita S: Spatio-temporal dual effects of IκBζ dictates the caution on visual disturbance resulting from IκBζ deficiency. Immunol Lett. 2010; 133(2): 115.
  106. Ueta M, Kinoshita S: Ocular surface inflammation mediated by innate immunity. Eye Contact Lens. 2010; 36(5): 269-281.
  107. Ueta M, Mizushima K, Yokoi N, Naito Y, Kinoshita S: Gene-expression analysis of polyI:C-stimulated primary human conjunctival epithelial cells. Br J Ophthalmol. 2010; 94(11): 1528-1532.
  108. Ueta M, Mizushima K, Yokoi N, Naito Y, Kinoshita S: Expression of the interleukin-4 receptor alpha in human conjunctival epithelial cells. Br J Ophthalmol. 2010; 94(9): 1239-1243.
  109. Kinoshita S, Ueta M: Innate immunity of the ocular surface. Jpn J Ophthalmol. 2010; 54(3): 194-198.
  110. Sotozono C, Ueta M, Kinoshita S: Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Am J Ophthalmol, 2010; 149(2): 354.
  111. Ueta M, Kinoshita S: Innate immunity of the ocular surface. Brain Res Bull. 2010; 81(2-3): 219-228.
  112. Sotozono C, Ueta M, Kinoshita S: The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis. Arch Dermatol, 2009; 145(11): 1336-1337.
  113. Honda T, Matsuoka T, Ueta M, Kabashima K, Miyachi Y, Narumiya S: Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. J Allergy Clin Immunol. 2009; 124(4): 809-818.
  114. Ueta M, Uematsu S, Akira S, Kinoshita S: Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol. 2009; 123(5): 1187-1189.
  115. Ueta M, Matsushita M, Sotozono C, Kinoshita S, Tokunaga K: Identification of a novel HLA-B allele, HLA-B*5904. Tissue Antigens. 2009; 73(6): 612-614.
  116. Ueta M, Sotozono C, Takahashi J, Kojima K, Kinoshita S: Examination of Staphylococcus aureus on the ocular surface of patients with catarrhal ulcers. Cornea. 2009; 28(7): 780-782.
  117. Araki Y, Sotozono C, Inatomi T, Ueta M, Yokoi N, Ueda E, Kishimoto S, Kinoshita S: Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol. 2009; 147(6): 1004-1011.
  118. Sotozono C, Ueta M, Koizumi N, Inatomi T, Shirakata Y, Ikezawa Z, Hashimoto K, Kinoshita S: Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology. 2009; 116(4): 685-690.
  119. Ueta M, Matsuoka T, Narumiya S, Kinoshita S: Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis. J Allergy Clin Immunol. 2009; 123(2): 466-471.
  120. Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Sawada J, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R: JSAR research group. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics. 2008; 9(11): 1617-1622.
  121. Ueta M: Innate immunity of the ocular surface and ocular surface inflammatory disorders. Cornea. 2008; 27(Suppl 1):S31-40.
  122. Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S: Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome. Br J Ophthalmol. 2008; 92(7): 989-991.
  123. Ueta M, Hamuro J, Ueda E, Katoh N, Yamamoto M, Takeda K, Akira S, Kinoshita S: Stat6-independent tissue inflammation occurs selectively on the ocular surface and perioral skin of IkappaBzeta-/- mice. Invest Ophthalmol Vis Sci. 2008; 49(8): 3387-3394.
  124. Ueta M, Tokunaga K, Sotozono C, Inatomi T, Yabe T, Matsushita M, Mitsuishi Y, Kinoshita S: HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese. Mol Vis. 2008; 14: 550-555.
  125. Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S: Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications. Invest Ophthalmol Vis Sci. 2008; 49(5): 1809-1813.
  126. Kojima K, Ueta M, Hamuro J, Hozono Y, Kawasaki S, Yokoi N, Kinoshita S: Human conjunctival epithelial cells express functional Toll-like receptor 5. Br J Ophthalmol. 2008; 92(3): 411-416.
  127. Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S: Association of IL4R polymorphisms with Stevens-Johnson syndrome. J Allergy Clin Immunol. 2007; 120(6): 1457-1459.
  128. Ueta M, Nakamura T, Tanaka S, Kojima K, Kinoshita S: Development of eosinophilic conjunctival inflammation at late-phase reaction in mast cell-deficient mice. J Allergy Clin Immunol. 2007; 120(2): 476-478.
  129. Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S: Toll like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol. 2007; 91(7): 962-965.
  130. Sotozono C, Ang LP, Koizumi N, Higashihara H, Ueta M, Inatomi T, Yokoi N, Kaido M, Dogru M, Shimazaki J, Tsubota K, Yamada M, Kinoshita S: New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Opthalmology. 2007; 114(7): 1294-1302.
  131. Ueta M, Sotozono C, Tokunaga K, Yabe T, Kinoshita S: Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese. Am J Ophthalmol. 2007; 143(2): 367-368.
  132. Ueta M, Iida T, Sakamoto M, Sotozono C, Takahashi J, Kojima K, Okada K, Chen X, Kinoshita S, Honda T: Polyclonality of Staphylococcus epidermidis residing on the healthy ocular surface. J Med Microbiol. 2007; 56(Pt 1): 77-82.
  133. Hozono Y, Ueta M, Hamuro J, Kojima K, Kawasaki S, Yamazaki K, Kinoshita S: Human corneal epithelial cells respond to ocular-pathogenic, but not to nonpathogenic-flagellin. Biochem Biophys Res Commun 2006; 347(1): 238-247.
  134. Naito Y, Takagi T, Mizushima K, Ueta M, Kinoshita S, Handa O, Kokura S, Ichikawa H, Yoshida N, Yoshikawa T: Gene expression clusters of a lipopolysaccharide-stimulated pathway in peripheral blood monocytes of Japanese patients with Crohn's disease. Aliment Pharmacol Ther. 2006; 24(Suppl 4): 256-265.
  135. Ono T, Park KS, Ueta M, Iida T, Honda T: Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1.Infect Immun. 2006; 74(2): 1032-1042.
  136. Ueta M, Hamuro J, Kiyono H, Kinoshita S: Triggering of TLR3 by polyI:C in human corneal epithelial cells to induce inflammatory cytokines. Biochem Biophys Res Commun. 2005; 331(1): 285-294.
  137. Ueta M, Hamuro J, Yamamoto M, Kaseda K, Akira S, Kinoshita S: Spontaneous ocular surface inflammation and goblet cell disappearance in I kappa B zeta gene-disrupted mice. Invest Ophthalmol Vis Sci. 2005; 46(2): 579-588.
  138. Ueta M, Nochi T, Jang MH, Park EJ, Igarashi O, Hino A, Kawasaki S, Shikina T, Hiroi T, Kinoshita S, Kiyono H: Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol. 2004; 173(5): 3337-3347.
  139. Ueta M, Kweon MN, Sano Y, Sotozono C, Yamada J, Koizumi N, Kiyono H, Kinoshita S: Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol, 2002; 129(3): 464-470.

和文

  1. 松本佳保里 , 福岡　秀記 , 富田　晃光 , 峠岡理沙 , 稲富勉 , 上田真由美 , 外園　千恵 : 急性期に川崎病との鑑別を要したStevens-Johnson症候群の１例 、日本眼科学会雑誌 日本眼科学会, 122 (9): 705-710, 2018.
  2. 中路進之助, 上田真由美, 外園千恵, 稲富勉, 木下茂 : 眼合併症を伴う日本人Stevens-Johnson症候群のHLA classI解析. 日本眼科学会雑誌, 116(6): 581-587, 2012.
  3. 佐々木美帆, 外園千恵, 千原秀美, 上田真由美, 稲富勉, 横井則彦, 塩田恒三, 木下茂 : 初期アカントアメーバ角膜炎の臨床所見に関する検討. 日本眼科学会雑誌, 114(12): 1030-1035, 2010.
  4. 中村さや花, 外園千恵, 稲富勉, 上田真由美, 塩田恒三, 木下茂 : 多数のアメーバと細菌がコンタクトレンズに付着していたアカントアメーバ角膜炎の２例. あたらしい眼科, 27(1): 85-89, 2010.
  5. 細谷友雅, 外園千恵, 稲富勉, 上田真由美, 福岡秀記, 内海隆夫, 保科幸次, 神野早苗, 三村治, 木下茂: 抗癌剤TS-1の全身投与が原因と考えられた角膜上皮障害. 臨床眼科, 61(6): 969－973, 2007.
  6. 高橋亜矢子, 政岡則夫, 上田真由美, 高橋徹, 上野脩幸 : まむし咬傷後に片眼内直筋麻痺をきたした１例. 眼科臨床医報, 93(12): 1727-1729, 1999.
  7. 松下久美子, 政岡則夫, 小松丈記, 上野脩幸, 上田真由美 : 視力の再低下をきたしたPurtscher網膜症の２症例. 眼科, 41(7): 911-916, 1999.
  8. 岸茂, 森貴久, 澤田章宏, 上田真由美 : 経皮的脳血管形成術が有効であった眼虚血症候群の２症例. 眼紀, 49(5): 404-409, 1998.
  9. 上田真由美, 政岡則夫, 北川康介, 上野脩幸 : 脈絡膜腫瘍２症例におけるインドシアニングリーン蛍光眼底造影所見. 眼科臨床医報, 87(9): 1927-1932, 1993.
  10. 政岡則夫, 上田真由美, 渡辺牧夫, 細木敬三, 上野脩幸, 高橋伊都子 : Perfluorodecalinによる硝子体腔内脱臼水晶体摘出術. 眼科臨床医報, 86(9): 2094-2097, 1992.
  11. 福島敦樹, 小倉典子, 上田真由美, 松本浩子, 上野ひさ幸, 沢田章宏 : 続発性眼窩腫瘍（Mucocele, Pyocele）のDynamic MRI. 日本眼科紀要, 42(9): 1925-1932, 1991.
  12. 野田幸作, 上田真由美: 眼内レンズ手術後の眼圧とカルバコール点眼（続報）. IOL, 5(4): 341-343, 1991.

総説

  1. 上田真由美 : Stevens-Johnson症候群と結膜変化, あたらしい眼科, 2019.9
  2. 上田真由美 : Stevens-Johnson症候群・中毒性表皮壊死症 増刊号 実戦 メディカル眼科治療アップデート メディカル眼科治療 各論 Ⅰ 外眼部疾患・前眼部疾患・屈折異常 臨床眼科 Vol.73 No.11　2019.10
  3. 上田真由美 : 眼アレルギーにおける結膜上皮細胞の免疫学的動態、アレルギー性眼疾患 update 6 月刊アレルギーの臨床 (Allergy in Practice) 541 ページ 2020.5、(株)北隆館
  4. 上田真由美 : 重症薬疹と眼障害, あたらしい眼科Vol.35 No.10 p53 (2018年10月号)
  5. 上田真由美 : アトピー性角結膜炎と慢性期スティーブンス・ジョンソン症候群の涙液中サイトカインプロファイルの相違、臨床免疫・アレルギー科 第70巻第4号373-378科学評論社（2018年10月発行）
  6. 上田真由美 : 「Ikaros family zink finger 1の皮膚粘膜炎症への関与」臨床免疫・アレルギー科　2018，70(2)，136－144，科学評論社
  7. 上田真由美 : 感冒薬に関連して発症するStevens-Johnson症候群の遺伝素因と病態解明.「バイオサイエンスとインダストリー」2018.5.10. 第76巻第3号、p213-217, （一財）バイオインダストリー協会
  8. 上田真由美 : 感冒薬で重症薬疹を発症することがあると聞きましたが、本当ですか？「循環制御」2018.5.1. 第39巻第1号、p48-56,
  9. 上田真由美 : 木下茂. 特集　あなたはゲノムをみて診療をしますか？　角膜疾患. あたらしい眼科. 2017.7.30, Vol.34，No.7, 929-937, メディカル葵出版社.
  10. 上田真由美 : 特集　研修医が知っておくべき境界領域疾患、小児の結膜炎. 小児科診療. 2017.5.1, Vol.80，No.5, 569-573, 診断と治療社.
  11. 峠岡理沙, 上田真由美, 加藤則人: 「アトピー性皮膚炎におけるToll-like receptor 3に役割の解明」アレルギーの臨床 2016, 36(4), 82(384)-88(390).
  12. 上田真由美 : Stevens-Johnson症候群眼障害を重症化させないポイントを教えてください、あたらしい眼科臨時増刊号. 2016, Vol.33，249-253, メディカル葵出版社
  13. 上田真由美、外園千恵 : 非定型抗酸菌角膜炎、臨床眼科増刊号. 2016, 第70巻、第11号、，217-222, 医学書院.
  14. 上田真由美 :点眼薬関連アレルギー：偽眼類天疱瘡、わかりやすい臨床講座、日本の眼科、2016, 第87巻、第7号、公益社団法人、日本眼科医会
  15. 上田真由美 : 感冒薬に関連した発症した眼合併型Stevens-Johnson症候群の新規疾患関連遺伝子IKZF1. 臨床免疫・アレルギー科　2013, 65 (5)， 446-451. 科学評論社
  16. 上田真由美 : 重篤な眼合併症と伴うStevens-Johnson症候群の発症予測. 特集・眼の先制医療. 2016あたらしい眼科. 2016.4.30, Vol.33:No.4, p501-510, メディカル葵出版社
  17. 上田真由美 : ドライアイリサーチアワード、ドライアイベストリサーチアワード受賞論文、感冒薬に関連した発症した眼合併型Stevens-Johnson症候群の発症関連遺伝子IKZF1. Frontiers in Dry Eye, 2016, Vol.11 No.1: p32-35, メディカルレビュー社.
  18. 上田真由美: 結膜アレルギーの基礎知識. あたらしい眼科. 2015.4.30, Vol.32:No.4, p519-520, メディカル葵出版社
  19. 上田真由美: 眼科におけるStevens-Johnson症候群の病型ならびに遺伝素因.あたらしい眼科. 2015, Vol.32: No.1, p59-67, メディカル葵出版社
  20. 上田真由美, 外園千恵: 眼表面のMRSA感染症について教えてください. 眼科診療のエッセンスQ&A.　あたらしい眼科臨時増刊号. 2014, Vol.31: p28-29, メディカル葵出版社.
  21. 上田真由美 : 外園千恵.重症薬疹と眼障害. アレルギー・免疫2014, Vol.21,No.8: p88-96. 医薬ジャーナル社
  22. 上田真由美, 外園千恵: 重篤な眼合併症を伴うStevens-Johnson症候群ならびに中毒性表皮壊死症. 図で早わかり実戦！眼科薬理、臨床眼科　2013年増刊号 Vol.67,No.11: p132-139, 医学書院
  23. 上田真由美, 外園千恵: Stevens-Johnson症候群の眼障害. 目でみる皮膚科学Visual Dermatology . 2013, Vol.12 No.2: p172-174, 秀潤社.
  24. 上田真由美 : プロスタグランジンE2による自然免疫性炎症の抑制.臨床免疫・アレルギー科　2013, 60 (6): 619-627. 科学評論社.
  25. 上田真由美 : 外園千恵. 重篤な眼合併症を伴うStevens-Johnson症候群ならびに中毒性表皮壊死症. 臨床眼科. 2013年増刊号. Vol.67. no.11. p132, 医学書院
  26. 上田真由美：眼表面疾患におけるTLRs. 臨床眼科. 2012年増刊号. Vol.66. no.11. p335, 医学書院
  27. 上田真由美：結膜上皮細胞によるアレルギー性結膜好酸球浸潤抑制. 臨床免疫・アレルギー科. 2011, 56(5): 495-502, 科学評論社
  28. 上田真由美: 微生物認識受容体とインフラマソーム. あたらしい眼科. 2011, vol.28 No.9: p1291-1292, メディカル葵出版社.
  29. 上田真由美 : 外園千恵: Stevens-Johnson症候群における眼のケアについて教えてください. 皮膚科の臨床 “日常診療で盲点となる皮膚科疾患”. 2011, 第53巻 第11号: p1618-1622, 金原出版株式会社.
  30. 上田真由美: 重症薬疹における遷延性上皮欠損. あたらしい眼科. 2011, vol.28 No.4: p501-502, メディカル葵出版社.
  31. 外園千恵, 上田真由美, 木下茂: 皮膚粘膜眼症候群の眼後遺症. 特集　全身疾患と眼. 日本医師会雑誌.2010. 第139巻 第8号: p1646, 日本医師会.
  32. 上田真由美: 眼表面炎症疾患における自然免疫応答異常の証明と発症機序の解明. アレルギア. 2010, No.39: p74-78, 日本アレルギー協会.
  33. 上田真由美, 外園千恵: Stevens-Johnson症候群の診断と治療―Up Date. Frontiers in Dry Eye, 2010, Vol.5 No.2: p16-21, メディカルレビュー社.
  34. 上田真由美,外園千恵: 重症薬疹Stevens-Johnson症候群の眼合併症について. カラーグラフ. 週刊日本医事新報. 2010, No.4494: p65-68, 日本医事新報社.
  35. 上田真由美, 外園千恵: 重症薬疹Stevens-Johnson症候群ならびに中毒性表皮壊死融解症の眼病変. ４.皮膚疾患治療のポイント. 臨床皮膚科. 2010, 第64巻 第5号 増刊号: P94-98, 医学書院.
  36. 上田真由美: Toll-like Receptorについて教えてください. あたらしい眼科臨時増刊号. 2009, Vol.26: p222-225, メディカル葵出版社.
  37. 上田真由美, 外園千恵: Stevens-Johnson症候群の眼症状と眼局所投与（点眼液 vs 眼軟膏）目でみる皮膚科学Visual Dermatology . 2009, Vol.8 No.3: p264-265, 秀潤社.
  38. 上田真由美: 遷延性角膜上皮欠損. あたらしい眼科. 2009, vol.26 No.2: p199-200, メディカル葵出版社.
  39. 上田真由美, 外園千恵, 木下茂: 「“難病”診療の最前線」Stevens-Johnson症候群の診療ならびに病態解析. 2008, Vol.117 No.10: p793-799, 京都府立医科大学雑誌.
  40. 外園千恵, 上田真由美: Stevens-Johnson症候群の眼科的対処. アレルギー. 2008, Vol.57 No.8: p995-999, 日本アレルギー学会.
  41. 上田真由美: 自然免疫と眼表面炎症性疾患. あたらしい眼科. 2008, Vol.25 No.6: p821-822, メディカル葵出版社.　
  42. 上田真由美: 上皮細胞によるアレルギー炎症制御. あたらしい眼科. 2008, Vol.25 No.2: p171-176, メディカル葵出版社.
  43. 上田真由美, 木下茂: 眼表面の自然免疫と眼表面炎症性疾患. 実験医学増刊号 粘膜免疫からの感染と免疫応答機構. 2007, Vol.25 No.20: p30-36, 羊土社.
  44. 上田真由美: 角膜疾患Q&A　臨床編　Stevens-Johnson症候群について教えてください. あたらしい眼科臨時増刊号. 2007, Vol.23: p64-67, メディカル葵出版社.
  45. 木下茂, 外園千恵, 稲冨勉, 中村隆宏, 小泉範子, 川崎諭, 上田真由美, 横井則彦, 上野盛夫, 笹井芳樹: 再生医学による重症角膜疾患の新規治療法開発への戦略的研究. 最新医学. 2007, 62巻1号: p132-180, 最新医学社.
  46. 上田真由美: 眼表面の自然免疫とTLRs. 感染・炎症・免疫. 2006, Vol.36 No.2: ｐ156-159, 医薬の門社.
  47. 上田真由美, 外園千恵: 眼科医のための最先端医療. 眼表面の自然免疫とToll-like receptor. あたらしい眼科. 2006, Vol.23 No.4: p485-487, メディカル葵出版社.
  • 国際拠点形成事業　A先端拠点形成型の活動内容・成果等
  • 研究メンバー